Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India.

Hdl Handle:
http://hdl.handle.net/10144/235558
Title:
Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India.
Authors:
Isaakidis, P; Varghese, B; Mansoor, H; Cox, H S; Ladomirska, J; Saranchuk, P; Da Silva, E; Khan, S; Paryani, R; Udwadia, Z; Migliori, G B; Sotgiu, G; Reid, T
Journal:
PloS One
Abstract:
Significant adverse events (AE) have been reported in patients receiving medications for multidrug- and extensively-drug-resistant tuberculosis (MDR-TB & XDR-TB). However, there is little prospective data on AE in MDR- or XDR-TB/HIV co-infected patients on antituberculosis and antiretroviral therapy (ART) in programmatic settings.
Affiliation:
Médecins Sans Frontières, Mumbai, India.
Publisher:
PLoS
Issue Date:
Jul-2012
URI:
http://hdl.handle.net/10144/235558
DOI:
10.1371/journal.pone.0040781
PubMed ID:
22792406
Language:
en
ISSN:
1932-6203
Appears in Collections:
TB

Full metadata record

DC FieldValue Language
dc.contributor.authorIsaakidis, Pen_GB
dc.contributor.authorVarghese, Ben_GB
dc.contributor.authorMansoor, Hen_GB
dc.contributor.authorCox, H Sen_GB
dc.contributor.authorLadomirska, Jen_GB
dc.contributor.authorSaranchuk, Pen_GB
dc.contributor.authorDa Silva, Een_GB
dc.contributor.authorKhan, Sen_GB
dc.contributor.authorParyani, Ren_GB
dc.contributor.authorUdwadia, Zen_GB
dc.contributor.authorMigliori, G Ben_GB
dc.contributor.authorSotgiu, Gen_GB
dc.contributor.authorReid, Ten_GB
dc.date.accessioned2012-07-24T14:45:24Z-
dc.date.available2012-07-24T14:45:24Z-
dc.date.issued2012-07-
dc.identifier.citationAdverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India. 2012, 7 (7):e40781 PLoS ONEen_GB
dc.identifier.issn1932-6203-
dc.identifier.pmid22792406-
dc.identifier.doi10.1371/journal.pone.0040781-
dc.identifier.urihttp://hdl.handle.net/10144/235558-
dc.description.abstractSignificant adverse events (AE) have been reported in patients receiving medications for multidrug- and extensively-drug-resistant tuberculosis (MDR-TB & XDR-TB). However, there is little prospective data on AE in MDR- or XDR-TB/HIV co-infected patients on antituberculosis and antiretroviral therapy (ART) in programmatic settings.en_GB
dc.language.isoenen
dc.publisherPLoSen_GB
dc.rightsPublished by Public Library of Science, [url]http://www.plosone.org/[/url] Archived on this site by Open Access permissionen_GB
dc.titleAdverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India.en
dc.contributor.departmentMédecins Sans Frontières, Mumbai, India.en_GB
dc.identifier.journalPloS Oneen_GB

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.